Juliet Barker, MBBS
Enriched profileDirector, Bone Marrow Transplant and Cell Therapy Program, Weill Cornell-NewYork Presbyterian · Weill Cornell Medicine
Juliet Barker is Director, Bone Marrow Transplant and Cell Therapy Program, Weill Cornell-NewYork Presbyterian at Weill Cornell Medicine. ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 19 Oct 2026
Overview
Updated 22 Oct 2026
Juliet Barker, MBBS, is Director, Bone Marrow Transplant and Cell Therapy Program, Weill Cornell-NewYork Presbyterian at Weill Cornell Medicine (Cornell University), with NewYork-Presbyterian Hospital. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 5 companies.
- Top research focus: Lymphoma
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 22 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
Sponsor: Memorial Sloan Kettering Cancer Center
- Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.
Sponsor: Memorial Sloan Kettering Cancer Center
- A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy
Sponsor: Memorial Sloan Kettering Cancer Center
Industry payments
Updated 22 Oct 2026
5 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- Iovance Biotherapeutics, Inc.Program year20251 payment
- Incyte CorporationProgram year20241 payment
- Iovance Biotherapeutics, Inc.Program year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
100%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor100%Acyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
New England Journal of Medicine
2020 - Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most
Biology of Blood and Marrow Transplantation
2018
Background & recognition
Updated 22 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
Editorial & leadership roles
journal and society appointments- Board member
American Society for Transplantation and Cellular Therapy (ASTCT)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗ - Co-Chair
Cord Blood Special Interest Group, American Society for Transplantation and Cellular Therapy
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →community.astct.org ↗ - Member
Advisory Council on Blood Stem Cell Transplantation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗ - Leadership role
National Cord Blood Network Inc.
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jedd Wolchok, MD
Weill Cornell Medicine
Richard Devereux, MD
Weill Cornell Medicine
Ronald Crystal, MD
Weill Cornell Medicine
Robert Harrington, MD
Weill Cornell Medicine
Seth Steinberg, PhD
National Cancer Institute (NCI)
Gilles Salles
Memorial Sloan Kettering Cancer Center
Wyndham Wilson, MD
National Cancer Institute (NCI)
Julie Vose, MD
University of Nebraska Medical Center